FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed

The FDA on Wednesday approved Taiho Oncology’s Lonsurf (tipiracil) as part of a combination regimen with Roche’s Avastin (bevacizumab) for the treatment of metastatic colorectal cancer.